| A significantly increased risk of hospitalisation for ischaemic stroke was observed 31–60 days post ranibizumab injection. |
| No increased risk of hospitalisation for myocardial infarction was observed in any time period post ranibizumab injection. |
| Whilst the absolute risk of ischaemic stroke is likely to be small, clinicians should be aware of the potential for increased risk of stroke with ranibizumab. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.